Skip to main content

Table 1 Clinical characteristics and laboratory results

From: Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review

Parameters

Before amyloidosis treatment

At 1-year follow-up

Clinical characteristics

 - Number of joints involved

19

11

 - CHAQ-DI score

1.37

1.25

Immunology

 - IL-6, pg/mL

624.5 (0–7)

528.7 (0–7)

 - ESR, mm/h

72 (5–20)

10 (5–20)

 - CRP, mg/L

76.23 (<5)

3.40 (<5)

  1. Data are presented as the laboratory result with reference range in parentheses unless otherwise indicated
  2. CHAQ-DI Childhood Health Assessment Questionnaire Disability Index, IL-6 interleukin-6, ESR erythrocyte sedimentation rate, CRP C-reactive protein